Financials

  • Market Capitalization 92.35 M
  • Employee 10
  • Founded 2012
  • CEO N/A
  • Website www.atarabio.com
  • Headquarter Delaware, United States
  • FIGI BBG005Q3MQY4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.64
ratio cours/chiffre d'affaires
25.04

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3950
KLRS
Kalaris Therapeutics, Inc. - Common Stock
4.03 USD-1.71%-2.42%+16.81%-60.61%95.93 M USD
3971
FBIO
Fortress Biotech, Inc. - Common Stock
2.77 USD-1.07%-2.12%-15.29%+1.84%92.38 M USD
3973
PYPD
PolyPid Ltd. - Ordinary Shares
5.07 USD-0.98%-0.98%+14.97%+49.56%92.29 M USD
3978
ICCC
ImmuCell Corporation - Common Stock
9.94 USD-0.80%-1.19%-10.69%+58.03%90.28 M USD

Nouvelles